Siegfried Holding AG SFZN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SFZN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CHF 861.00
- Day Range
- CHF 857.00–871.00
- 52-Week Range
- CHF 655.00–950.00
- Bid/Ask
- CHF 863.00 / CHF 886.00
- Market Cap
- CHF 3.73 Bil
- Volume/Avg
- 3,861 / 6,597
Key Statistics
- Price/Earnings (Normalized)
- 23.58
- Price/Sales
- 2.94
- Dividend Yield (Trailing)
- 0.42%
- Dividend Yield (Forward)
- 0.42%
- Total Yield
- 0.56%
Company Profile
Siegfried Holding AG is a biotechnology company that focuses on primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. The company broadly offers complex oral and sterile formulations of drug products available for custom development and manufacturing, as well as licensing.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,180
- Website
- https://www.siegfried.ch
Comparables
Valuation
|
Metric
|
SFZN
|
543434
|
PPGN
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.58 | 24.67 | — |
Price/Book Value | 4.86 | 4.01 | 3.08 |
Price/Sales | 2.94 | 5.54 | 3.50 |
Price/Cash Flow | 16.92 | 28.18 | — |
Price/Earnings
SFZN
543434
PPGN
Financial Strength
|
Metric
|
SFZN
|
543434
|
PPGN
|
|---|---|---|---|
Quick Ratio | 1.35 | 3.14 | 1.09 |
Current Ratio | 2.47 | 6.26 | 1.85 |
Interest Coverage | 17.11 | 192.48 | −9.37 |
Quick Ratio
SFZN
543434
PPGN
Profitability
|
Metric
|
SFZN
|
543434
|
PPGN
|
|---|---|---|---|
Return on Assets (Normalized) | 7.09% | — | −6.13% |
Return on Equity (Normalized) | 17.53% | — | −9.58% |
Return on Invested Capital (Normalized) | 10.47% | — | −7.07% |
Return on Assets
SFZN
543434
PPGN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Qhxwsgtlf | Bxq | $76.6 Bil | |
MKKGY
| Merck KGaA ADR | Wdlnqlvqq | Bmyqs | $72.3 Bil | |
HLN
| Haleon PLC ADR | Clnjvncf | Dbcvb | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dqnvrhdq | Vcmh | $18.3 Bil | |
VTRS
| Viatris Inc | Jkkzfznk | Pgdq | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fmzkgkqx | Pdxq | $11.8 Bil | |
CTLT
| Catalent Inc | Mrvlbxyv | Hlsprdj | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Gttpjjz | Ptvvz | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Tzzdzcctw | Pzr | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qsbhkhnc | Nzwbgbt | $3.5 Bil |